版本:
中国

BRIEF-Inovio pharmaceuticals says AstraZeneca's MedImmune will start new clinical trial

May 10 Inovio Pharmaceuticals Inc

* Inovio provides update on MedImmune launch of combination trial for hpv-associated head & neck cancer

* Inovio Pharmaceuticals-AstrazZneca's medimmune will start a new clinical trial investigating combination of medi0457

* Inovio Pharmaceuticals-new clinical trial will investigate combination of medi0457 and durvalumab, an investigational pd-l1 checkpoint inhibitor Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐